Anbio Biotechnology (NASDAQ:NNNN) Stock Price Up 6.7% – Should You Buy?

Anbio Biotechnology (NASDAQ:NNNN) rose 6.7% during mid-day trading on Wednesday . The company traded as high as $17.26 and last traded at $17.25. Approximately 8,704 shares traded hands during mid-day trading, a decline of 80% from the average daily volume of 43,359 shares. The stock had previously closed at $16.16.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings upgraded shares of Anbio Biotechnology from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Thursday, May 14th. One research analyst has rated the stock with a Hold rating, Based on data from MarketBeat.com, Anbio Biotechnology has an average rating of “Hold”.

Anbio Biotechnology Stock Performance

The firm’s 50-day simple moving average is $27.31.

Anbio Biotechnology (NASDAQ:NNNN) last released its earnings results on Tuesday, April 7th. The company reported $0.03 earnings per share (EPS) for the quarter.

About Anbio Biotechnology

Anbio Biotechnology is dedicated to the advancement of medical technology and the provision of in vitro diagnostics (IVD) products. Our unwavering commitment lies in transforming the diagnostics landscape on a global scale, fostering a paradigm shift towards personalized and decentralized diagnostic solutions. By doing so, we aim to significantly enhance patient prognosis and contribute to the betterment of healthcare worldwide. At Anbio Biotechnology, our extensive portfolio comprises an array of IVD products designed to cater to diverse diagnostic needs.